Glyceryl triacetate for Canavan disease: A low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model
- C. N. Madhavarao
- , P. Arun
- , J. R. Moffett
- , A. M.A. Namboodiri*
- , Y. Anikster
- , S. R. Mog
- , O. Staretz-Chacham
- , N. E. Grunberg
- , W. A. Gahl
*Corresponding author for this work
- Uniformed Services University of the Health Sciences
- Sheba Medical Center at Tel Hashomer
- AFRRI
- National Institutes of Health
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations